Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 16;14:719–728. doi: 10.2147/DMSO.S288482

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Ji et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

IRS-2 is the potential target of miR-7a. (A) qRT-PCR analysis was done for studying the levels of miR-7a in endothelial cells and Retinal pericytes co-transfected with miR-7a mimic or mimic control.(B) qRT-PCR analysis in endometrial cells and Retinal pericytes co-transfected with miR-7a inhibitor or control.(C) The IRS-2 3ʹUTR having potential binding site for miR-7a. (D) The Endothelial cells co-transfected with miR-7a mimic or control luciferase vector having wild type or mutant IRS-2 3ʹUTR. (E) Results of luciferase assay in endothelial cells transfected with miR-7a inhibitor or control, the luciferase results were normalized against renilla luciferase. Results are presented as the mean ± standard deviation (n=3). *P<0.05 compared to other groups, ^@P<0.05 compared to miR-7a mimic control.